The deregulation of the PI3K/Akt/mTOR pathway plays a fundamental role in breast cancer, such that the pharmacological suppression of PI3K/Akt/mTOR signalling showed inhibition of tumor growth in vivo [31]. This evidence concerns the gene MTOR and breast carcinoma.